Advanced regulatory compliance solutions for extreme environments and cybersecurity.
Product-specific consulting for medical device regulation and cybersecurity
We provide consulting for product-specific regulatory strategy, technical documentation, clinical evaluation and post-market activities under the EU Medical Device Regulation, Regulation (EU) 2017/745 (MDR).
We support medical-device cybersecurity risk management throughout development and premarket and postmarket activities. Applicability of FD&C Act section 524B to cyber devices, FDA recommendations and relevant EU MDR requirements is reviewed for each product.
Addressing machinery safety and cybersecurity under the EU Machinery Regulation
The main requirements of Regulation (EU) 2023/1230 (EU MR) apply from 20 January 2027. Annex III section 1.1.9 addresses protection of safety-critical hardware, software and data against accidental or intentional corruption. Section 1.2.1 addresses control-system safety and reliability under external influences, including reasonably foreseeable malicious attempts.
We review how connectivity, remote access and software changes can affect safety functions, and support risk assessment, protective measures and verification evidence. Concurrent CRA applicability and conformity assessment procedures are reviewed for each product.
Systematic manufacturing quality for explosion-protected products
For ATEX, manufacturer quality-assessment requirements depend on the product category and chosen conformity assessment procedure. For IECEx, we support the ExTR and QAR requirements of the applicable certification scheme. Services include ISO/IEC 80079-34 quality-system preparation and applicable QAN/QAR audit support.
"Navigating rapidly changing digital regulations: turning business risks into opportunities."
CRA vulnerability and incident reporting obligations apply from 11 September 2026; its main product obligations apply from 11 December 2027. The RED cybersecurity delegated regulation has applied to specified radio equipment since August 2025 and will be repealed from 11 December 2027 in coordination with the CRA. Product scope and exclusions are reviewed individually.
We agree the appropriate deliverables, such as a requirements matrix, gap analysis, risk assessment, quality procedures or technical documentation.
Prepare product specifications and operating conditions, target markets, and existing certification, test and quality documentation.